Value Assessment Model

Company considering acquiring the rights to a new treatment for a rare disease with little experience in value-based pricing and health economics

Reviewed disease area literature to understand quality of life and costs, benefit of treatment, as well as market share and revenue forecasts. Developed an integrated value assessment model (VAM) that allowed the team to test changes in the target product profile and pricing methodology on the overall value

Provided a clear understanding of the direct impact on financial value from changes to product characteristics, as well as the ability to run sensitivity analysis around key uncertainties/scenarios